- Home
- / CeleCor Therapeutics
CeleCor Therapeutics
CeleCor Therapeutics Summary
Company Summary
- Overview
- CeleCor Therapeutics is a company that provides a solution supporting the treatment of serious heart attacks. It develops RUC-4, a small molecule platelet inhibitor of the platelet GPIIb/IIIa (αIIbβ3) receptor, designed for single dose subcutaneous administration.
- Type
- Private
- Status
- Active
- HQ
- Del Mar, CA, US | view all locations
- Website
- https://www.celecor.com
- Cybersecurity rating
Table of Contents
Key People
Robert S. Hillman, President & CEO, Co-Founder
Andreas Ritzi, Member, Board of Directors Co-Founder
Peter B. Finn, Corporate Secretary